Moderna’s COVID-19 Vaccine Price Will Be Test of US Negotiating Power
Executive Summary
Drug pricing experts are concerned the US government may not follow through on its commitment to pay less for COVID-19 vaccines it has helped fund given reports Moderna may be pushing a $50-$60/course price. The US also has little ability to control pricing in the private market – even for some government payers.